MEDVi Tirzepatide Cost 2026: What You Actually Pay

MEDVi does not publish its tirzepatide price on its homepage. You reach it by completing a medical intake quiz, which is standard for telehealth weight programs and mildly annoying if you are just trying to budget.

This page collects what is publicly verifiable about the program, what the price includes, and how it sits against the alternatives.

Price verification pending. We are confirming MEDVi’s current tirzepatide pricing directly with the company rather than repeating figures from other sites. Third-party sources currently quote a range, and we have found those figures inconsistent. This section will be updated with a dated, verified number. See our methodology.

What the MEDVi program includes

MEDVi bundles medication into the program price rather than billing separately. According to the company’s published materials, enrolment includes:

• Prescription for compounded GLP-1 medication, subject to clinician approval
• Consultation with a licensed provider
• 1:1 physician guidance
• Dietitian visits and care coaching
• 24/7 support
• Shipping

That bundling matters when comparing prices. A program at $250 with coaching included is not $50 more expensive than one at $200 that charges separately for consultations.

Who actually provides the care

This is the part most reviews skip, and it is the part worth understanding.

MEDVi is not a pharmacy and does not manufacture medication. Clinical care is delivered through OpenLoop Health, a network of US-licensed clinicians, operating through affiliated professional corporations. The prescribing decision sits with an OpenLoop clinician after an online consultation, not with MEDVi.

Medication is dispensed by third-party compounding pharmacies. MEDVi names three publicly:

Naming the pharmacies is a genuine transparency signal. Most telehealth platforms do not, and the FDA has repeatedly flagged sourcing opacity as a problem in this category. MEDVi is also LegitScript-certified, which is verifiable independently.

The counterweight: OpenLoop is one of a small number of clinical networks that sits behind a large share of the direct-to-consumer GLP-1 market. A STAT News analysis in March 2026 found that a significant portion of the telehealth companies that received FDA warning letters shared clinical affiliations with just four medical groups, OpenLoop among them. That is not a finding about MEDVi specifically, and shared infrastructure is not itself a violation — but it is context worth having.

What “compounded” means for your wallet

Compounded tirzepatide is prepared by a compounding pharmacy rather than by the original manufacturer. It does not go through the same premarket review for safety, effectiveness, or manufacturing quality, and it is not therapeutically equivalent to brand-name tirzepatide.

MEDVi states this plainly in its own disclosures, which is more than some competitors do.

For pricing purposes, three consequences:

No insurance. Compounded medication is not covered. Every dollar is out of pocket.

No manufacturer assistance. Savings cards, patient assistance programs, and the Medicare GLP-1 Bridge apply to brand-name products only.

Regulatory exposure. The FDA has issued three large waves of warning letters to telehealth companies marketing compounded GLP-1 products since September 2025, and has proposed permanently restricting large-scale compounding of tirzepatide and semaglutide. If you are budgeting a year ahead, budget for the possibility that compounded supply narrows.

How it compares

The honest comparison is not MEDVi against other compounded programs. It is compounded against brand.

If you have commercial insurance that covers Zepbound, no compounded program can compete. $25 beats everything, and you get the brand product.

If you are on Medicare, check GLP-1 Bridge eligibility before anything else. It launched 1 July 2026.

If you are paying cash and uninsured, the comparison narrows to compounded programs versus LillyDirect at $299–$449. That is a real decision, and it turns on price, what is bundled, and how much the regulatory uncertainty bothers you.

See our full tirzepatide cost breakdown for every route, including the refill timing rule that quietly doubles some LillyDirect prices.

Questions to ask before enrolling

Ask these of MEDVi or any compounded program. The answers vary more than the advertised prices do. We put the same questions to every program in our provider reviews.

1. What is the price at maintenance dose, not starter dose? Entry pricing is not the number you will pay in month four.
2. Which pharmacy will prepare my medication? MEDVi names three; ask which one serves your state.
3. Is there a membership fee on top of the medication?
4. What is the cancellation policy, and is there a refund window?
5. What happens to my prescription if compounded supply is restricted?
6. Does the price change if I switch from tirzepatide to semaglutide?

The verdict

MEDVi does more than most on transparency: named pharmacies, LegitScript certification, and clear labelling of its products as compounded and not federally approved. The bundled model — medication, consultations, dietitian, coaching — is genuinely more complete than programs that charge for each piece.

The structural caveats apply to the whole compounded category rather than to MEDVi in particular: no insurance, no manufacturer assistance, and a regulatory picture that has been narrowing for a year.

It makes sense for one specific person: uninsured or without GLP-1 coverage, paying cash, wanting clinical support bundled in, and comfortable with a compounded product after discussing it with a clinician.

It makes no sense for anyone with commercial coverage. Check your formulary first. Then check it again.

This is educational information about cost and program structure, not medical advice. Whether tirzepatide is appropriate for you is a decision between you and a licensed clinician.